Vimarsana
Biggest News Aggregation in the World

B Clear Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Clear Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Clear Phase Today - Breaking & Trending Today

20 Countries with Free Health Care - Insider Monkey - Vimarsana News

20 Countries with Free Health Care - Insider Monkey

The U.S. is one of the only advanced countries in the world to not have free healthcare, which is said to cost the country trillions of dollars.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript - Vimarsana News

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript August 9, 2023 Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.6, expectations were $-0.94. Operator: Good morning, and welcome to Ionis’ Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn […]

Source: yahoo.com
GSK plc (NYSE:GSK) Q2 2023 Earnings Call Transcript - Vimarsana News

GSK plc (NYSE:GSK) Q2 2023 Earnings Call Transcript

Nick Stone: Hello, everyone. Welcome to our Half Year End Q2 2023 conference call webcast investors and analysts.

Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen - Vimarsana News

Ionis announces positive data from GSK's Phase 2b clinical study of bepirovirsen

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that GSK presented positive end of study data from the Phase 2b B-Clear study of...

Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ - Vimarsana News

Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), today announced that GSK presented positive results from an interim analysis of the Phase 2b...